Abstract
Ventricular tachycardia is a common and lethal complication after myocardial infarction. Here we show that focal transfer of a gene encoding a dominant-negative version of the KCNH2 potassium channel (KCNH2-G628S) to the infarct scar border eliminated all ventricular arrhythmias in a porcine model. No proarrhythmia or other negative effects were discernable. Our results demonstrate the potential viability of gene therapy for ablation of ventricular arrhythmias.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
American Heart Association. 2001 Heart and Stroke Statistical Update. (American Heart Association, Dallas, 2002).
Rothman, S. et al. Circulation 96, 3499–3508 (1997).
Gould, P., Krahn, A. & Canadian Heart Rhythm Society Working Group on Device Advisories. JAMA 295, 1907–1911 (2006).
Maisel, W. et al. J. Am. Med. Assoc. 295, 1901–1906 (2006).
Sanguinetti, M.C., Curran, M.E., Spector, P.S. & Keating, M.T. Proc. Natl. Acad. Sci. USA 93, 2208–2212 (1996).
Lesh, M., Pring, M. & Spear, J. Circ. Res. 65, 1426–1440 (1989).
Donahue, J.K. et al. Nat. Med. 6, 1395–1398 (2000).
Miake, J., Marban, E. & Nuss, H. Nature 419, 132–133 (2002).
Qu, J. et al. Circulation 107, 1106–1109 (2003).
Brunner, M. et al. Am. J. Physiol. Heart Circ. Physiol. 285, H194–H203 (2003).
Quinones, M. et al. Circulation 94, 1394–1401 (1996).
Snyder, R. et al. Nat. Genet. 16, 270–276 (1997).
Kafri, T. et al. Nat. Genet. 17, 314–317 (1997).
Acknowledgements
This work was funded by grants from the US National Institutes of Health. ICD equipment was donated by St. Jude Inc. Basket catheters and electrogram mapping system were donated by Boston Scientific Corp.
Author information
Authors and Affiliations
Contributions
T.S. designed the study, carried out experiments, performed analyses and assisted in writing the paper; A.D.M. assisted with performing and troubleshooting the experiments; K.K. assisted with design of the model and performing experiments; and J.K.D. conceived and designed the study, performed analyses and took the primary role in writing the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
EP study before and after gene transfer. (PDF 23 kb)
Supplementary Fig. 2
Validation of quantitative RT-PCR. (PDF 491 kb)
Supplementary Fig. 3
Dofetilide infusion in the post-MI VT model. (PDF 23 kb)
Supplementary Table 1
Echocardiography data (PDF 7 kb)
Supplementary Table 2
ECG and EP study data (PDF 10 kb)
Rights and permissions
About this article
Cite this article
Sasano, T., McDonald, A., Kikuchi, K. et al. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat Med 12, 1256–1258 (2006). https://doi.org/10.1038/nm1503
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1503
This article is cited by
-
New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models
Scientific Reports (2023)
-
Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy
Nature Communications (2022)
-
Heterogeneous repolarization creates ventricular tachycardia circuits in healed myocardial infarction scar
Nature Communications (2022)
-
Angiotensin Receptor Neprilysin Inhibitor Attenuates Myocardial Remodeling and Improves Infarct Perfusion in Experimental Heart Failure
Scientific Reports (2019)
-
A role for membrane shape and information processing in cardiac physiology
Pflügers Archiv - European Journal of Physiology (2015)